These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 6577602)

  • 1. Tumor-derived growth factor increases bone resorption in a tumor associated with humoral hypercalcemia of malignancy.
    Ibbotson KJ; D'Souza SM; Ng KW; Osborne CK; Niall M; Martin TJ; Mundy GR
    Science; 1983 Sep; 221(4617):1292-4. PubMed ID: 6577602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EGF receptor antiserum inhibits bone resorbing activity produced by a rat Leydig cell tumor associated with the humoral hypercalcemia of malignancy.
    Ibbotson KJ; D'Souza SM; Smith DD; Carpenter G; Mundy GR
    Endocrinology; 1985 Jan; 116(1):469-71. PubMed ID: 2981075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-purification of transforming growth factor beta-like activity with PTH-like and bone-resorbing activities from a tumor associated with humoral hypercalcemia of malignancy.
    Insogna KL; Weir EC; Wu TL; Stewart AF; Broadus AE; Burtis WJ; Centrella M
    Endocrinology; 1987 May; 120(5):2183-5. PubMed ID: 3494596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical and histomorphometric characterization of a rat model for humoral hypercalcemia of malignancy.
    Insogna KL; Stewart AF; Vignery AM; Weir EC; Namnum PA; Baron RE; Kirkwood JM; Deftos LM; Broadus AE
    Endocrinology; 1984 Mar; 114(3):888-96. PubMed ID: 6546543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The hypercalcemic rat Leydig cell tumor--a model of the humoral hypercalcemia of malignancy.
    Sica DA; Martodam RR; Aronow J; Mundy GR
    Calcif Tissue Int; 1983 May; 35(3):287-93. PubMed ID: 6871760
    [No Abstract]   [Full Text] [Related]  

  • 6. The effects of dichloromethylene diphosphonate on hypercalcemia and other parameters of the humoral hypercalcemia of malignancy in the rat Leydig cell tumor.
    Martodam RR; Thornton KS; Sica DA; D'Souza SM; Flora L; Mundy GR
    Calcif Tissue Int; 1983 Jul; 35(4-5):512-9. PubMed ID: 6311375
    [No Abstract]   [Full Text] [Related]  

  • 7. Increased production of tumor necrosis factor by normal immune cells in a model of the humoral hypercalcemia of malignancy.
    Sabatini M; Yates AJ; Garrett IR; Chavez J; Dunn JF; Bonewald L; Mundy GR
    Lab Invest; 1990 Nov; 63(5):676-82. PubMed ID: 2232714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Separation of parathyroid hormone-like activity from transforming growth factor-alpha and -beta in the canine adenocarcinoma (CAC-8) model of humoral hypercalcemia of malignancy.
    Merryman JI; Rosol TJ; Brooks CL; Capen CC
    Endocrinology; 1989 May; 124(5):2456-63. PubMed ID: 2539981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skeletal response in rats following the implantation of hypercalcemia-producing Leydig cell tumors.
    Tam CS; Heersche JN; Santora A; Spiegel AM
    Metabolism; 1984 Jan; 33(1):50-3. PubMed ID: 6690886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of humoral hypercalcemia of malignancy in rats with inhibitors of carbonic anhydrase.
    Brown GM; Morris CA; Mitnick MA; Insogna KL
    J Bone Miner Res; 1990 Oct; 5(10):1037-41. PubMed ID: 1964358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The hypercalcemia of cancer. Clinical implications and pathogenic mechanisms.
    Mundy GR; Ibbotson KJ; D'Souza SM; Simpson EL; Jacobs JW; Martin TJ
    N Engl J Med; 1984 Jun; 310(26):1718-27. PubMed ID: 6328302
    [No Abstract]   [Full Text] [Related]  

  • 12. The combined effect of tumor-produced parathyroid hormone-related protein and transforming growth factor-alpha enhance hypercalcemia in vivo and bone resorption in vitro.
    Guise TA; Yoneda T; Yates AJ; Mundy GR
    J Clin Endocrinol Metab; 1993 Jul; 77(1):40-5. PubMed ID: 8325957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Humoral hypercalcemia of malignancy. Release of a prostaglandin-stimulating bone-resorbing factor in vitro by human transitional-cell carcinoma cells.
    Bringhurst FR; Bierer BE; Godeau F; Neyhard N; Varner V; Segre GV
    J Clin Invest; 1986 Feb; 77(2):456-64. PubMed ID: 3003159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ascites sarcoma 180, an animal model of humoral hypercalcemia of malignancy, produces a factor(s) exhibiting potent bone-resorbing activity without any parathyroid hormone-like activity.
    Suzuki K; Yamada S
    Bone Miner; 1991 Jul; 14(1):1-13. PubMed ID: 1651137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leydig cell tumor induced hypercalcemia in the Fischer rat: morphometric and histochemical evidence for a humoral factor that activates osteoclasts.
    Troyer H; Sowers JR; Babich E
    Am J Pathol; 1982 Sep; 108(3):284-90. PubMed ID: 7114164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypereninemic hypoaldosteronism in association with neoplasia induced hypercalcemia in the Fischer rat.
    Sowers JR; Sollars E; Nyby MD; Jasberg K; Tuck ML
    Metabolism; 1981 Oct; 30(10):987-91. PubMed ID: 7024725
    [No Abstract]   [Full Text] [Related]  

  • 17. A mouse tumor-derived osteolytic factor stimulates bone resorption by a mechanism involving local prostaglandins production in bone.
    Lau KH; Lee MY; Linkhart TA; Mohan S; Vermeiden J; Liu CC; Baylink DJ
    Biochim Biophys Acta; 1985 May; 840(1):56-68. PubMed ID: 2986710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The tumor cells (FA-6) established from a pancreatic cancer associated with humoral hypercalcemia of malignancy: a simultaneous production of parathyroid hormone-like activity and transforming growth factor activity.
    Nagata N; Akatsu T; Kugai N; Yasutomo Y; Kinoshita T; Kosano H; Shimauchi T; Takatani O; Ueyama Y
    Endocrinol Jpn; 1989 Feb; 36(1):75-85. PubMed ID: 2543550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production of granulocyte-stimulating and bone cell-modulating activities from a neutrophilia hypercalcemia-inducing murine mammary cancer cell line.
    Lee MY; Liu CC; Lottsfeldt JL; Judkins SA; Howard GA
    Cancer Res; 1987 Aug; 47(15):4059-65. PubMed ID: 3496955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resorbing bone stimulates tumor cell growth. A role for the host microenvironment in bone metastasis.
    Manishen WJ; Sivananthan K; Orr FW
    Am J Pathol; 1986 Apr; 123(1):39-45. PubMed ID: 3457536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.